Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines), By Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, Swine Influenza), By Target Disease (Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, Swine Influenza), By Region & Competition, 2020-2030F

Market Overview

Global Swine Vaccines Market was valued at USD 1.32 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.85% through 2030. The global swine vaccines market is a vital segment of the animal health industry that focuses on preventing and managing diseases in swine populations. Swine vaccines play a crucial role in ensuring the health and productivity of pigs in the swine farming sector, which is a significant component of the global meat industry. For instance, according to the World Population Review’s Pork Consumption Data 2024, global pork consumption stands at 112.6 kilotons and is expected to rise to 129 kilotons by 2031. This increasing demand, especially in Asia-Pacific, Europe, and North America, underscores the need for healthy and productive swine herds. To sustain supply and quality, pig producers are prioritizing disease prevention through effective vaccination, driving market growth as they adopt advanced biosecurity measures to enhance herd health and efficiency.

Key Market Drivers

Rising Demand for Pork

The world's population is steadily increasing, and with it, the demand for protein-rich foods like pork is on the rise. As more people move to urban areas, their dietary preferences tend to shift towards meat-based diets. This urbanization trend amplifies the demand for pork products, leading to larger swine farming operations. To meet this burgeoning demand, farmers rely on swine vaccines to ensure the health and productivity of their herds.

Emerging markets in regions such as Asia, Latin America, and Africa are witnessing a rapid expansion of their middle-class populations. As incomes rise, so does the consumption of animal protein, including pork. This socio-economic shift is a major driver of increased demand for pork and, consequently, for swine vaccines. To meet the quality and safety standards demanded by this growing middle-class consumer base, swine farmers invest in disease prevention through vaccination.

Food security is a pressing concern in a world that needs to feed a growing population sustainably. Pork is an efficient source of protein, as pigs can convert feed into meat relatively quickly compared to other livestock. Ensuring the health and well-being of swine herds through vaccination is a key component of sustainable swine farming. Healthy pigs mean higher yields, reduced waste, and a more sustainable food supply chain.

Disease outbreaks in swine herds can lead to significant economic losses. Swine vaccines are essential tools for preventing and mitigating the impact of diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and African swine fever (ASF). The ability to safeguard swine populations from these diseases not only protects the livestock but also ensures a stable and reliable supply of pork.

In an era where consumers are increasingly concerned about food safety and animal welfare, swine vaccines play a crucial role in reassuring consumers about the quality of pork products. Vaccination programs are seen as responsible and proactive measures by farmers and producers to maintain the health of their animals. This confidence in the quality and safety of pork products further bolsters consumer demand.

Advancements in biotechnology and vaccine development have resulted in the creation of more effective and safer swine vaccines. These innovations have improved disease prevention while minimizing the need for antibiotics and other treatments. The availability of advanced vaccines enhances the attractiveness of swine farming and supports market growth.

Disease Prevention and Management

Disease outbreaks in swine herds can result in devastating economic consequences. Swine diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, African swine fever (ASF), and foot-and-mouth disease can cause mass mortalities, reduced growth rates, and increased veterinary and treatment costs. Swine vaccines serve as a cost-effective and proactive measure to mitigate these economic losses by preventing diseases before they occur. For instance, between January 2022 and August 2024, African Swine Fever (ASF) has been detected in 61 countries across five regions, affecting over 704,000 pigs and 21,600 wild boars, with total animal losses surpassing 1.7 million. This widespread outbreak highlights the critical need for preventive strategies, accelerating investment in vaccine development and adoption to curb further economic and agricultural impacts.

Sustainability in agriculture is a growing global concern, and the swine industry is no exception. Disease prevention through vaccination is a critical component of sustainable swine farming. Healthy swine herds are more efficient in terms of feed conversion and produce less waste, reducing the environmental footprint of pig farming. Swine vaccines enable farmers to practice responsible and sustainable animal husbandry.

Also, in September 2024, MSD Animal Health secured marketing authorization from the European Medicines Agency (EMA) for PORCILIS PCV M Hyo ID, a ready-to-use intradermal vaccine. This innovative solution provides protection against Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo), offering enhanced convenience and efficacy for swine producers, ultimately improving herd health and disease management.

Biosecurity measures alone are not always sufficient to prevent disease outbreaks in swine farms. The introduction of pathogens can occur through various vectors, including wildlife, transportation, and farm personnel. Swine vaccines complement biosecurity practices by providing an additional layer of protection. A well-structured vaccination program can significantly reduce the risk of disease introduction and spread.

In today's interconnected world, diseases can spread rapidly across borders. Globalization has increased the movement of people, animals, and goods, making the swine industry more susceptible to transboundary diseases. Swine vaccines play a vital role in controlling and containing these diseases, safeguarding the global pork supply chain.

Regulatory authorities in different countries have established guidelines and regulations governing the use of swine vaccines. Compliance with these regulations is not only a legal requirement but also essential for ensuring the safety and efficacy of vaccines. Farmers and producers are more likely to invest in vaccination programs that meet regulatory standards, further driving the growth of the swine vaccines market.

Consumers are becoming more conscious of food safety and animal welfare. Swine vaccines are viewed as a responsible and proactive means of maintaining the health and welfare of swine herds. A healthier pig population results in safer and higher-quality pork products, meeting the demands of discerning consumers.

Advancements in Vaccine Technology

Traditional vaccines often provide broad protection against a range of pathogens, but advancements in vaccine technology have enabled the development of more precise and targeted vaccines. This means that vaccines can be tailored to specific swine diseases, addressing the unique challenges faced by swine farmers. Precision in vaccination not only enhances disease prevention but also minimizes the potential for adverse reactions. For instance, in June 2023, Boehringer Ingelheim Animal Health Canada Inc. launched an innovative single-dose vaccine designed to protect pigs against Porcine Circovirus Type 2 (PCV2) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSv). Utilizing a proprietary purification process, this breakthrough enables the seamless combination of Ingelvac CircoFLEX with Ingelvac PRRS MLV, ensuring effective disease protection without compromising vaccine efficacy.

One significant advancement is the development of vaccines with reduced side effects. Modern vaccines are designed to be safer, with fewer adverse reactions in swine populations. This increased safety profile provides farmers and producers with more confidence in vaccinating their herds, leading to greater adoption of vaccination programs.

Advancements in vaccine technology have resulted in vaccines that are more effective in preventing diseases. Modern vaccines stimulate a stronger and longer-lasting immune response in swine, providing a higher level of protection against pathogens. Improved vaccine efficacy is essential in reducing disease-related losses and increasing the overall health of swine herds.

New vaccine delivery systems have made vaccine administration more convenient for farmers. These systems include oral vaccines, nasal sprays, and vaccines administered via drinking water, reducing the stress on animals and simplifying the vaccination process. As a result, farmers are more likely to incorporate vaccines into their herd management practices.

Advancements in biotechnology have accelerated the development of swine vaccines. The ability to identify and characterize swine pathogens more quickly allows for the rapid development of vaccines to combat emerging diseases or evolving strains. This agility is crucial in staying ahead of disease threats in the swine industry.

The swine industry faces constant challenges from evolving pathogens and emerging diseases. Advancements in vaccine technology allow for more timely updates and modifications to existing vaccines. This adaptability ensures that swine vaccines remain effective in an ever-changing disease landscape.

Global Expansion of Swine Farming

The world's population continues to surge, particularly in regions like Asia, Latin America, and Africa. With this population growth comes an increased demand for protein-rich foods, including pork. Swine farming is an efficient way to produce high-quality protein, making it a key player in global food security. As swine herds expand to meet this demand, swine vaccines are essential for preventing diseases and ensuring a stable supply of pork.

Emerging economies are witnessing a significant rise in middle-class populations, leading to increased disposable incomes and changing dietary habits. In many of these regions, pork is a staple protein source. This shift towards a higher protein diet is driving the expansion of swine farming operations to meet the demands of this growing consumer base. Swine vaccines play a crucial role in protecting these valuable livestock assets.

Pork consumption patterns vary across the globe, influenced by cultural preferences and dietary habits. While pork is a dietary staple in some regions, it is considered a delicacy in others. Swine vaccines are equally relevant in both scenarios, as they help maintain herd health and prevent disease outbreaks, regardless of the scale of pork production.

Swine farming provides a livelihood for millions of people, particularly in rural areas of developing countries. As swine farming expands, it creates employment opportunities and economic growth in these regions. Disease prevention through vaccination is essential to protect the livelihoods of farmers and ensure the sustainability of swine farming as a source of income.

Globalization has facilitated the movement of goods and people, including the international trade of livestock and livestock products. However, it has also increased the risk of disease transmission across borders. Swine vaccines are vital tools in controlling and containing diseases, safeguarding global pork supply chains, and ensuring the safe movement of swine and swine products.

Consumer expectations regarding food safety and quality are on the rise. Swine vaccines play a crucial role in ensuring the health and welfare of swine herds, resulting in safer and higher-quality pork products. The use of vaccines is seen as a responsible and proactive measure by farmers and producers to meet these stringent standards.

Download Free Sample Report

Key Market Challenges

Emerging Diseases and Pathogens

The swine industry faces an ongoing threat from emerging diseases and evolving strains of existing pathogens. New diseases, such as African swine fever (ASF) and novel strains of influenza, can have devastating consequences for swine herds. Developing effective vaccines to combat these emerging threats is a constant challenge for vaccine manufacturers.

Vaccine Safety and Efficacy

Ensuring the safety and efficacy of swine vaccines is paramount. Vaccine manufacturers must invest in rigorous testing and clinical trials to demonstrate the effectiveness and safety of their products. Developing vaccines with a high level of safety and minimal side effects is an ongoing challenge.

Storage and Distribution Challenges

Maintaining the cold chain for vaccine storage and distribution can be challenging in some regions, especially in remote or less developed areas. Ensuring that vaccines reach their intended recipients in optimal condition is crucial for their effectiveness.

Biosecurity Risks

Biosecurity breaches can lead to disease outbreaks within swine herds, rendering vaccination efforts ineffective. Controlling access to farms, proper quarantine procedures, and employee training are essential aspects of biosecurity, but they can be challenging to enforce consistently.

Key Market Trends

Precision Vaccination

One of the emerging trends in the swine vaccines market is precision vaccination. Traditional vaccines provide broad protection against a range of pathogens, but advances in vaccine technology now allow for more precise targeting of specific diseases. This trend helps swine farmers address unique disease challenges and reduce the potential for adverse reactions.

Next-Generation Vaccine Platforms

The development of next-generation vaccine platforms is transforming the landscape of swine vaccination. These platforms include mRNA vaccines and viral vector vaccines, which offer improved safety, efficacy, and ease of administration. As research in these areas’ advances, we can expect to see more innovative vaccine solutions tailored to swine health.

Digitalization and Data-Driven Decisions

The integration of digital technology in swine farming, often referred to as "smart farming," is gaining momentum. Farmers are using sensors, data analytics, and real-time monitoring to track the health of their herds. This data-driven approach enables more precise vaccination timing and enhances overall disease management.

Disease Surveillance and Monitoring

Surveillance and monitoring of swine diseases are crucial for early detection and containment. Advances in diagnostic tools, including rapid and cost-effective tests, are making it easier for swine farmers to identify diseases promptly, allowing for more effective vaccination strategies.

Segmental Insights

Product Insights

Based on the category of product, the category of inactivated vaccines held a dominant position in the market and contributed the most substantial portion of revenue in 2024. This can be attributed to several factors, including their easy accessibility, cost-effectiveness, and stability advantages when compared to live-attenuated vaccines. Inactivated vaccines are effective in minimizing the risk of pathogens regaining virulence after vaccination since they halt the replication process of these harmful agents.  They offer swine enhanced immunization with a swift cell-mediated immune response. The immunity achieved through inactivated vaccines can be further bolstered by the inclusion of adjuvants like specific types of oils or aluminum hydroxide. However, it is crucial to exercise significant caution when preparing, storing, and handling inactivated vaccines to ensure their efficacy.

Type Insights

Based on the category of Type, the PRRS (Porcine Reproductive and Respiratory Syndrome) category emerged as the dominant force in the market, securing the largest share of revenue in 2022. This can be attributed to its widespread occurrence in key swine-raising nations. PRRS manifests in both endemic and epidemic forms in the United States and select Asian countries. In the U.S., it has maintained epidemic status for over three decades, while in China, a leading player in the swine industry, it has been considered an epidemic for more than two decades. The significant genetic variability of the virus, stemming from common errors during RNA transcription, poses a formidable challenge in controlling the diversity of isolates, even within the same country.

Conversely, other swine diseases like ileitis, Glasser's disease, and neonatal diarrhea, among others, are projected to experience the highest CAGR during the forecast period. This growth is attributed to their high prevalence in swine herds located in developing economies. For instance, according to the CAB International organization, as of 2019, Glasser's disease had established a wide presence in various Asian, European, and American countries. Similarly, other disease outbreaks, such as erysipelas, occur separately in both acute and chronic forms or in a sequential manner, resulting in substantial economic losses. Specific vaccines tailored to each type of swine disease are available to effectively manage and control such outbreaks within farms.

Download Free Sample Report

Regional Insights

In 2024, Asia Pacific secured the largest portion of revenue, and it is projected to experience the most rapid CAGR during the forecast period. Several key factors contribute to this substantial market share. Notably, the region is home to major swine-producing nations, with China at the forefront. Additionally, the Asia Pacific region boasts a sizable population with a strong appetite for meat, driving a significant demand for vaccines to combat the increasing incidence of diseases among Asian swine herds. Asia had the highest pig population in 2021, numbering 462.6 million pigs, with China leading the pack with approximately 347 million pigs. China's pork consumption reached 43,843 thousand tonnes in 2021.

In other regions such as Latin America, North America, and Europe, the swine vaccines market is also expected to witness substantial growth in the coming years. This growth can be attributed to the increasing swine population and the widespread adoption of biosecurity measures, including routine vaccination. North America, in particular, held a significant share of revenue in 2022. This is due to the region's well-established veterinary healthcare infrastructure, a growing demand for animal protein, highly organized farming practices, and an increased investment in animal health. Countries like the United States and Canada benefit from robust and well-defined healthcare systems and a concentration of key industry players.

Recent Developments

• In September 2024, Merck & Co., Inc. obtained marketing authorization from the European Medicines Agency (EMA) for PORCILIS PCV M Hyo ID, an intradermal vaccine designed for swine. This approval marks a significant advancement in swine health management, enhancing disease prevention and biosecurity. Such regulatory milestones strengthen the adoption of innovative veterinary vaccines, fostering overall market expansion and improving livestock productivity.
• In July 2024, South Africa made a significant breakthrough in the fight against African Swine Fever (ASF) as the FDA and DA BAI approved the country’s first ASF vaccine. This milestone aims to control disease outbreaks, ensure herd protection, and stabilize the pork industry, ultimately strengthening the meat supply chain and supporting economic growth in the livestock sector.
• In May 2022, Boehringer Ingelheim introduced TwistPak, an innovative blending system enabling swine producers to easily and dependably combine two vaccines, Ingelvac MycoFLEX and Ingelvac CircoFLEX.
• In March 2022, Boehringer Ingelheim unveiled the ReproCyc ParvoFLEX vaccine, specifically designed to provide safe and effective protection for healthy gilts and sows aged six months or older against reproductive failure attributed to porcine parvovirus. 

Key Market Players

• Merck & Co Inc
• Zoetis Inc
• Boehringer Ingelheim GmbH
• Elanco Animal Health Inc
• Indian Immunologicals Ltd
• Biogénesis Bagó SA
• Phibro Animal Health Corp
• Laboratorios HIPRA SA
• Virbac SA

Report Scope:

In this report, the Global Swine Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Swine Vaccines Market, By Product:

o   Attenuated Live Vaccines

o   DNA Vaccines

o   Inactivated Vaccines

o   Recombinant Vaccines

o   Subunit Vaccines

• Swine Vaccines Market, By Type:

o   Actinobacillus Pleuropneumoniae

o   Classical Swine Fever

o   Foot & Mouth Disease

o   PEDV

o   Porcine Circovirus Type 2

o   Porcine Parvovirus

o   PRRS

o   Pseudorabies

o   Swine Influenza

• Swine Vaccines Market, By Target Disease:

o   Arthritis

o   Bordetella Rhinitis

o   Diarrhea

o   Foot & Mouth Disease

o   Porcine Circovirus Associated Disease

o   Porcine Reproductive & Respiratory Syndrome

o   Pseudorabies

o   Swine Influenza

• Swine Vaccines Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Vaccines Market.

Available Customizations:

Global Swine Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Swine Vaccines Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com